デフォルト表紙
市場調査レポート
商品コード
1383709

解剖病理市場- 世界の産業規模、シェア、動向、機会、予測、2018年-2028年、タイプ別、技術別、用途別、エンドユーザー別、地域別、競合

Anatomic Pathology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type, By Technique, By Application, By End-User By Region and Competition

出版日: | 発行: TechSci Research | ページ情報: 英文 178 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.13円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

解剖病理市場- 世界の産業規模、シェア、動向、機会、予測、2018年-2028年、タイプ別、技術別、用途別、エンドユーザー別、地域別、競合
出版日: 2023年10月03日
発行: TechSci Research
ページ情報: 英文 178 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の解剖病理市場は、2022年に360億9,000万米ドルと評価され、2028年までのCAGRは7.90%で、予測期間中に力強い成長が予測されています。

世界の解剖病理市場は、組織や細胞を顕微鏡レベルで検査することで病気を診断し理解する、ヘルスケア産業におけるダイナミックで重要な分野です。この市場には、臨床検査、診断機器、関連消耗品など、幅広い製品とサービスが含まれます。2021年9月に私が最後に知識をアップデートした時点では、この分野は著しい成長とイノベーションを経験していました。

世界の解剖病理市場の主な促進要因の1つは、世界の慢性疾患とがんの罹患率の上昇です。人口の高齢化とライフスタイルの変化に伴い、正確でタイムリーな診断情報に対する需要が急増し、解剖病理サービスの利用が増加しています。さらに、デジタル病理学や分子診断学などの技術の進歩が病理学検査の精度と効率を高め、市場の成長をさらに促進しています。

さらに、ヘルスケアの世界化と遠隔医療の導入により、解剖病理サービスの範囲が拡大し、国境を越えた遠隔診察や病理データの共有が可能になっています。これにより、患者の治療が改善されただけでなく、市場拡大の新たな道も開かれました。

市場概要
予測期間 2024-2028
市場規模2022年 360億9,000万米ドル
2028年の市場規模 564億9,000万米ドル
CAGR 2023-2028 7.90%
急成長セグメント 創薬・医薬品開発
最大市場 北米

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の解剖病理市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別(組織病理、細胞病理、外科病理、その他)
    • 技術別(特殊染色、免疫組織化学、電子顕微鏡、遺伝子検査、その他)
    • 用途別(疾病診断、創薬・医薬品開発)
    • エンドユーザー別(病院、調査研究所、診断研究所、その他)
    • 地域別
    • 企業別(2022年)
  • 市場マップ
    • タイプ別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 地域別

第5章 アジア太平洋の解剖病理市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • オーストラリア
    • 日本
    • 韓国

第6章 欧州の解剖病理市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • スペイン
    • イタリア
    • 英国

第7章 北米の解剖病理市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 技術別
    • エンドユーザー別
    • 用途別
    • 国別
  • 北米国別分析
    • 米国
    • メキシコ
    • カナダ

第8章 南米の解剖病理市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 技術別
    • エンドユーザー別
    • 国別
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第9章 中東・アフリカの解剖病理市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 薬剤タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • MEA:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • エジプト

第10章 市場力学

  • 促進要因
  • 課題

第11章 市場動向と発展

  • 最近の動向
  • 製品上市
  • 合併と買収

第12章 SWOT分析

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • Quest Diagnostics Inc
  • Danaher Corporation
  • PHC Holdings Corporation
  • Laboratory Corporation of America Holdings
  • F. Hoffmann-La Roche AG
  • Agilent Technologies Inc.
  • Cardinal Health Inc.
  • Sakura Finetek USA Inc.
  • NeoGenomics Laboratories Inc.
  • BioGenex.

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 17403

Global Anatomic Pathology Market has valued at USD 36.09 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 7.90% through 2028. The Global Anatomic Pathology Market is a dynamic and vital sector within the healthcare industry, dedicated to the diagnosis and understanding of diseases through the examination of tissues and cells at a microscopic level. This market encompasses a wide range of products and services, including laboratory testing, diagnostic equipment, and related consumables. As of my last knowledge update in September 2021, it was a sector experiencing significant growth and innovation.

One of the primary drivers of the global anatomic pathology market is the rising incidence of chronic diseases and cancer worldwide. With an aging population and changing lifestyle factors, the demand for accurate and timely diagnostic information has surged, leading to increased utilization of anatomic pathology services. Additionally, advancements in technology, such as digital pathology and molecular diagnostics, have enhanced the precision and efficiency of pathology testing, further propelling market growth.

Furthermore, the globalization of healthcare and the adoption of telemedicine have expanded the reach of anatomic pathology services, allowing for remote consultations and the sharing of pathology data across borders. This has not only improved patient care but also opened up new avenues for market expansion.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 36.09 Billion
Market Size 2028USD 56.49 Billion
CAGR 2023-20287.90%
Fastest Growing SegmentDrug Discovery and Development
Largest MarketNorth America

Key Market Drivers

Rising Incidence of Chronic Diseases and Cancer

The Global Anatomic Pathology Market is experiencing a notable boost due to the rising incidence of chronic diseases and cancer worldwide. This epidemiological trend has become a significant driver in the expansion of the anatomic pathology sector. Chronic diseases, including cardiovascular diseases, diabetes, and respiratory conditions, have been steadily increasing in prevalence, primarily attributed to factors such as aging populations, sedentary lifestyles, and poor dietary choices. Similarly, cancer, one of the most formidable health challenges, continues to grow in frequency, impacting millions of lives globally.

Anatomic pathology plays an indispensable role in the diagnosis and characterization of these diseases. Pathologists examine tissue and cell samples at a microscopic level, providing critical insights into disease progression, staging, and treatment planning. In the context of cancer, precise and timely pathological analysis is essential for determining the type of cancer, its aggressiveness, and the presence of specific biomarkers. This information guides oncologists in developing personalized treatment strategies, such as targeted therapies and immunotherapies, ultimately improving patient outcomes.

As the global healthcare landscape grapples with the increasing burden of chronic diseases and cancer, the demand for anatomic pathology services continues to surge. This heightened demand is not only driven by the sheer volume of cases but also by the need for accurate and comprehensive diagnostic information. Patients and healthcare providers alike are recognizing the pivotal role that anatomic pathology plays in delivering effective and personalized care. Moreover, the integration of technology, such as digital pathology and molecular diagnostics, into anatomic pathology practices has enhanced the precision and efficiency of disease diagnosis. Digital pathology enables the remote viewing and analysis of pathology slides, facilitating consultations and second opinions from experts around the world. Molecular pathology techniques allow for the examination of genetic and molecular alterations within tissues, guiding the development of targeted therapies and immunotherapies.

Technological Advancements

Technological advancements are serving as a powerful catalyst, propelling the Global Anatomic Pathology Market to new heights. This critical healthcare sector, which involves the meticulous examination of tissues and cells at a microscopic level, has undergone a profound transformation thanks to cutting-edge innovations. These advancements are not only enhancing the accuracy and efficiency of anatomic pathology services but also broadening its appeal to healthcare providers and patients alike.

Digital pathology is at the forefront of these technological developments. It allows pathologists to digitize pathology slides, enabling remote viewing, sharing, and analysis. This shift from traditional microscopy to digital platforms has revolutionized pathology practices. Pathologists can collaborate with experts across the globe in real-time, leading to more accurate diagnoses and reducing geographical barriers to accessing expert opinions. Moreover, digital pathology streamlines workflow processes, increases efficiency, and minimizes the risk of human error, ultimately improving patient care.

Automation and artificial intelligence (AI) are also key contributors to the market's growth. Automated slide scanners can process large volumes of slides rapidly, freeing up pathologists' time for more complex tasks. AI algorithms can assist in the identification of abnormalities, further reducing diagnostic errors and increasing the speed of diagnosis. These technologies not only improve diagnostic precision but also enhance the overall cost-effectiveness of anatomic pathology services.

Molecular diagnostics is another area where technology has made significant inroads. This sub-discipline of anatomic pathology involves the examination of genetic and molecular alterations in tissues. Advances in molecular pathology techniques have enabled the detection of specific genetic markers and mutations, guiding targeted therapies and personalized treatment plans. The ability to identify these molecular signatures has revolutionized cancer diagnosis and treatment, ushering in an era of precision medicine. Furthermore, the integration of data analytics and big data in anatomic pathology has opened up new avenues for research and diagnostic insights. Pathologists can leverage vast datasets to identify trends, correlations, and predictive markers, contributing to a deeper understanding of disease mechanisms and progression..

Molecular Diagnostics

Molecular diagnostics has emerged as a powerful force driving the growth of the Global Anatomic Pathology Market. This specialized branch of anatomic pathology involves the examination of genetic and molecular alterations within tissues and cells, and its impact on the field has been transformative. Molecular diagnostics has become an invaluable tool in understanding and managing diseases, particularly in the context of cancer, and it continues to reshape the landscape of anatomic pathology.

One of the key ways in which molecular diagnostics contributes to the growth of the market is through its role in personalized medicine. By analyzing specific genetic and molecular markers within tissues, pathologists can provide precise information about a patient's disease. This information allows clinicians to tailor treatment plans to the individual, selecting therapies that are most likely to be effective while minimizing side effects. The ability to offer personalized treatment options not only improves patient outcomes but also increases the demand for molecular pathology services.

Furthermore, molecular diagnostics plays a pivotal role in cancer diagnosis and treatment. It enables pathologists to identify specific genetic mutations and biomarkers associated with different types of cancer. This information helps oncologists determine the most appropriate treatment strategies, including targeted therapies and immunotherapies. The accuracy and specificity of molecular diagnostics in characterizing tumors have significantly improved cancer care and prognosis, driving the need for more comprehensive molecular pathology services.

The growth of molecular diagnostics is also intertwined with advancements in technology. New techniques and tools for molecular analysis, such as next-generation sequencing and polymerase chain reaction (PCR), have made it possible to examine genetic and molecular alterations in tissues with unprecedented precision and speed. These technological advancements have expanded the scope and capabilities of molecular pathology, making it an indispensable component of modern healthcare.

Key Market Challenges

Reimbursement Issues

One of the primary concerns in the anatomic pathology market is the uncertainty surrounding reimbursement rates. Pathology services encompass a wide range of diagnostic tests, including histopathology, cytology, and molecular diagnostics, which often involve the use of sophisticated technologies and equipment. However, reimbursement rates for these services may not always reflect the true cost incurred by laboratories, particularly in cases where advanced diagnostic techniques are employed. This disparity between the cost of providing services and the reimbursement received can strain the financial viability of pathology laboratories, hampering their ability to invest in state-of-the-art equipment and technologies.

Moreover, the complexity of reimbursement systems and the variation in policies across different regions can further compound the challenges. Navigating the intricacies of billing, coding, and documentation requirements can be time-consuming and resource-intensive for pathology laboratories. This administrative burden not only adds overhead costs but can also lead to delays in reimbursement, affecting the cash flow of these facilities.

The impact of reimbursement issues extends beyond pathology laboratories; it can also influence patient access to advanced diagnostic services. When laboratories are constrained by inadequate reimbursement rates, they may be reluctant to offer certain tests or invest in the latest technologies.

Data Privacy and Security

The Global Anatomic Pathology Market, which revolves around the examination of tissues and cells at a microscopic level to diagnose diseases, faces a significant hurdle in the form of data privacy and security concerns. In an era where digital technologies are revolutionizing the healthcare landscape, the safe and confidential handling of patient data is paramount. However, the complexities of ensuring robust data protection in the field of anatomic pathology present substantial challenges.

One of the foremost concerns is the need to safeguard patient privacy. Pathology laboratories routinely handle sensitive patient information, including medical histories, genetic data, and diagnostic reports. Ensuring that this data remains confidential and protected from unauthorized access is critical to maintaining patient trust and complying with data privacy regulations such as HIPAA (Health Insurance Portability and Accountability Act) in the United States. Any breach of patient data can result in significant legal and financial consequences, as well as damage to the reputation of healthcare providers and institutions.

The adoption of digital pathology, which involves the digitalization of pathology slides and the sharing of pathology data across healthcare systems, amplifies data security challenges. Securely transmitting and storing large volumes of digital pathology images and patient data is a complex undertaking. Laboratories must invest in robust cybersecurity measures to prevent data breaches and unauthorized access to digital records. These measures encompass encryption, access controls, intrusion detection systems, and regular security audits..

Key Market Trends

Rapid Advancements in Digital Pathology

Rapid advancements in digital pathology are serving as a driving force behind the burgeoning Global Anatomic Pathology Market. Digital pathology, a transformative technology, involves the digitization of traditional glass pathology slides and the analysis of tissue specimens in a digital format. This innovation has been a game-changer in the field of anatomic pathology, bringing a multitude of benefits that are accelerating its growth and adoption worldwide.

One of the most significant contributions of digital pathology is its ability to improve the accuracy and efficiency of diagnostic processes. By converting glass slides into high-resolution digital images, pathologists can access and analyze tissue specimens remotely. This enables the seamless sharing of pathology slides across geographical boundaries, facilitating consultations with experts from different parts of the world. The collaborative nature of digital pathology not only enhances the quality of diagnostic decisions but also expedites patient care.

Artificial intelligence (AI) and machine learning are increasingly integrated into digital pathology platforms, opening new horizons for automation and diagnostic assistance. AI algorithms can assist pathologists in identifying abnormalities, quantifying biomarkers, and streamlining workflow processes. This trend is reducing the risk of human error, accelerating the pace of diagnosis, and ultimately improving patient outcomes. Additionally, AI-driven image analysis is enabling the identification of subtle morphological patterns and molecular markers that may be challenging to detect through traditional methods.

Furthermore, digital pathology is enabling the creation of vast digital archives of pathology data. These digital repositories allow for the retrospective analysis of pathology cases, which can lead to the discovery of new insights into disease progression and treatment outcomes. Researchers can harness this wealth of data to conduct retrospective studies and advance our understanding of various diseases, ultimately contributing to the development of more effective therapies.

Molecular Diagnostics and Personalized Medicine

Molecular diagnostics and personalized medicine are dynamic forces driving the growth of the Global Anatomic Pathology Market. These intertwined trends have revolutionized the field of anatomic pathology, offering profound insights into disease diagnosis, treatment, and patient care.

Molecular diagnostics, a cornerstone of anatomic pathology, focuses on the examination of genetic and molecular alterations within tissues and cells. This powerful approach enables pathologists to delve deep into the genetic makeup of diseases, providing precise information about their molecular characteristics. It is particularly influential in oncology, where it aids in identifying specific genetic mutations and biomarkers associated with different cancer types. This information guides oncologists in developing personalized treatment strategies, including targeted therapies and immunotherapies. As a result, patients benefit from therapies tailored to their unique genetic profiles, which often lead to more effective treatment outcomes and fewer adverse effects.

The rise of personalized medicine has dovetailed with the advances in molecular diagnostics. Personalized medicine tailors medical treatments to an individual's genetic and molecular makeup, aiming to maximize treatment efficacy while minimizing side effects. Anatomic pathology plays a pivotal role in this paradigm shift, providing the diagnostic insights necessary for personalized treatment plans. Molecular diagnostics allows pathologists to identify genetic mutations and molecular markers that influence disease progression and therapeutic responses. In addition to oncology, personalized medicine is extending its reach to other medical specialties, such as cardiology, gastroenterology, and neurology, where it is enhancing the precision and effectiveness of treatment approaches.

These trends are driving the demand for anatomic pathology services. Laboratories are increasingly offering molecular diagnostics to provide clinicians with the comprehensive information needed for personalized medicine. This shift is not only improving patient care but also expanding the market's scope and reach.

Segmental Insights

Application Insights

Based on the Application, the Disease Diagnosis emerged as the dominant segment in the global market for Global Anatomic Pathology Market in 2022. Anatomic pathology, with its expertise in examining tissues and cells at a microscopic level, is indispensable in diagnosing a wide range of diseases, including cancer, infectious diseases, autoimmune disorders, and more. As a result, disease diagnosis is a routine and essential part of healthcare, driving consistent demand for anatomic pathology services.

The global population is continually growing and aging, leading to an increased prevalence of chronic diseases and conditions. This demographic shift translates to a larger patient base requiring diagnostic services. Anatomic pathology plays a crucial role in diagnosing these diseases, making it a cornerstone of healthcare systems worldwide.

End-User Insights

Based on the End-User, the Hospitals segment emerged as the dominant player in the global market for Global Anatomic Pathology Market in 2022. Hospitals are primary healthcare institutions where patients seek diagnosis and treatment for various medical conditions. Anatomic pathology services, which involve the examination of tissues and cells for diagnostic purposes, are essential in diagnosing diseases, guiding treatment decisions, and monitoring patient progress. Given the central role of hospitals in patient care, they are the primary consumers of anatomic pathology services.

Hospitals typically serve a large and diverse patient population, including individuals with a wide range of medical conditions. This high patient volume results in a substantial demand for diagnostic services. Anatomic pathology laboratories in hospitals are equipped to handle the diverse diagnostic needs of patients, from routine histopathology examinations to specialized tests.

Regional Insights

North America emerged as the dominant player in the global Anatomic Pathology Market in 2022, holding the largest market share. North America boasts one of the most advanced healthcare infrastructures globally. The region is equipped with state-of-the-art medical facilities, cutting-edge technology, and a highly skilled workforce. This infrastructure supports the demand for anatomic pathology services, ensuring access to advanced diagnostic capabilities.

North America faces a growing burden of chronic diseases, including cancer, cardiovascular diseases, and diabetes. The prevalence of these conditions necessitates extensive diagnostic services, including anatomic pathology, for early detection, accurate diagnosis, and treatment planning.

Key Market Players

Quest Diagnostics Inc

Danaher Corporation

PHC Holdings Corporation

Laboratory Corporation of America Holdings

F. Hoffmann-La Roche AG

Agilent Technologies Inc.

Cardinal Health Inc.

Sakura Finetek USA Inc.

NeoGenomics Laboratories Inc.

BioGenex

Report Scope:

In this report, the Global Anatomic Pathology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Global Anatomic Pathology Market, By Type:

  • Histopathology
  • Cytopathology
  • Surgical Pathology
  • Others

Global Anatomic Pathology Market, By Technique:

  • Special Staining
  • Immunohistochemistry
  • Electron Microscopy
  • Genetic Testing
  • Others

Global Anatomic Pathology Market, By Application:

  • Disease Diagnosis
  • Drug Discovery and Development

Global Anatomic Pathology Market, By End-User:

  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Others

Global Anatomic Pathology Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Anatomic Pathology Market.

Available Customizations:

  • Global Anatomic Pathology Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Anatomic Pathology Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Type (Histopathology, Cytopathology, Surgical Pathology, Others)
    • 4.2.2. By Technique (Special Staining, Immunohistochemistry, Electron Microscopy, Genetic Testing, Others)
    • 4.2.3. By Application (Disease Diagnosis, Drug Discovery and Development)
    • 4.2.4. By End-User (Hospitals, Research Laboratories, Diagnostic Laboratories, Others)
    • 4.2.5. By Region
    • 4.2.6. By Company (2022)
  • 4.3. Market Map
    • 4.3.1. By Type
    • 4.3.2. By Technique
    • 4.3.3. By Application
    • 4.3.4. By End-User
    • 4.3.5. By Region

5. Asia Pacific Anatomic Pathology Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Technique
    • 5.2.3. By Application
    • 5.2.4. By End-User
    • 5.2.5. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Anatomic Pathology Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Type
        • 5.3.1.2.2. By Technique
        • 5.3.1.2.3. By Application
        • 5.3.1.2.4. By End-User
    • 5.3.2. India Anatomic Pathology Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Type
        • 5.3.2.2.2. By Technique
        • 5.3.2.2.3. By Application
        • 5.3.2.2.4. By End-User
    • 5.3.3. Australia Anatomic Pathology Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Type
        • 5.3.3.2.2. By Technique
        • 5.3.3.2.3. By Application
        • 5.3.3.2.4. By End-User
    • 5.3.4. Japan Anatomic Pathology Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Type
        • 5.3.4.2.2. By Technique
        • 5.3.4.2.3. By Application
        • 5.3.4.2.4. By End-User
    • 5.3.5. South Korea Anatomic Pathology Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Type
        • 5.3.5.2.2. By Technique
        • 5.3.5.2.3. By Application
        • 5.3.5.2.4. By End-User

6. Europe Anatomic Pathology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Technique
    • 6.2.3. By Application
    • 6.2.4. By End-User
    • 6.2.5. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Anatomic Pathology Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End-User
    • 6.3.2. Germany Anatomic Pathology Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End-User
    • 6.3.3. Spain Anatomic Pathology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End-User
    • 6.3.4. Italy Anatomic Pathology Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By Technique
        • 6.3.4.2.3. By Application
        • 6.3.4.2.4. By End-User
    • 6.3.5. United Kingdom Anatomic Pathology Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By Technique
        • 6.3.5.2.3. By Application
        • 6.3.5.2.4. By End-User

7. North America Anatomic Pathology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Technique
    • 7.2.3. By End-User
    • 7.2.4. By Application
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Anatomic Pathology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End-User
    • 7.3.2. Mexico Anatomic Pathology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End-User
    • 7.3.3. Canada Anatomic Pathology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End-User

8. South America Anatomic Pathology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Technique
    • 8.2.3. By End-User
    • 8.2.4. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Anatomic Pathology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End-User
    • 8.3.2. Argentina Anatomic Pathology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End-User
    • 8.3.3. Colombia Anatomic Pathology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End-User

9. Middle East and Africa Anatomic Pathology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Drug Type
    • 9.2.3. By Application
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Anatomic Pathology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End-User
    • 9.3.2. Saudi Arabia Anatomic Pathology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Drug Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End-User
    • 9.3.3. UAE Anatomic Pathology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End-User
    • 9.3.4. Egypt Anatomic Pathology Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Technique
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End-User

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Iron Deficiency Anemia: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Quest Diagnostics Inc
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Current Capacity Analysis
    • 14.1.5. Financials (In case of listed)
    • 14.1.6. Recent Developments
    • 14.1.7. SWOT Analysis
  • 14.2. Danaher Corporation
  • 14.3. PHC Holdings Corporation
  • 14.4. Laboratory Corporation of America Holdings
  • 14.5. F. Hoffmann-La Roche AG
  • 14.6. Agilent Technologies Inc.
  • 14.7. Cardinal Health Inc.
  • 14.8. Sakura Finetek USA Inc.
  • 14.9. NeoGenomics Laboratories Inc.
  • 14.10. BioGenex.

15. Strategic Recommendations

16. About Us & Disclaimer